Stay updated with breaking news from Pharma Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
![Asian International Arbitration Renaissance [Brought to you by M.B. Kemp] - Vimarsana News](https://vimarsana.com/images/vimarsana-bigimage.jpg)
In 2000, Asia’s share of global GDP was around 28%.[1] In 2019, Asia generated nearly 40% of the world’s GDP and is now home to nearly 60% of the world’s population. According to McKinsey & Co, “Asia is on track to top 50% of global GDP by 2040 and drive 40% of the world’s consumption, representing a real shift in the world’s centre of gravity.”[2]
The Irish Times Business Person of the Month: Matt Cooper Inflazome sells to Swiss pharma giant Roche for an initial €380 million Tue, Apr 13, 2021, 02:06 The spark behind Inflazome came when Australian chemist Matt Cooper met Irish immunologist Luke O’Neill at a medical conference. The two men brainstormed the role of inflammasomes - part of the body’s immune system - in a host of serious chronic diseases when they spiral out of control. Eight years later - and four years after the two men set up the company in Dublin - Inflazome was sold to Swiss pharma giant Roche for an initial...
Open Orphan plans for possible spin-out of non-core assets Company says HVO-001 could be included as part of potential demerger Tue, Apr 13, 2021, 07:45 Updated: Tue, Apr 13, 2021, 16:57 Dublin-listed pharmaceutical services company Open Orphan said it is planning for a possible spin-out of some of its non-core development intellectual property assets. The company said it believed the assets in question were best developed separately from the core services businesses to maximise shareholder value and could secure separate financial resources, enable accelerated development of thes...
CDC makes first public admission that there are efficacy problems with domestic jabs
Blueprint requires members of billionaire pharmacy family to relinquish control of company